Cytosolic Ca2+ domain-dependent protective action of adenosine in cardiomyocytes

A Jovanovic1, J R Lopez, A Terzic

  • 1Department of Medicine, Mayo Clinic, Mayo Foundation, Rochester, MN 55905, USA.

Insights

Resting cardiac cells show distinct calcium (Ca2+) domains. Adenosine

Area of Science:

  • Cardiology
  • Cell Physiology
  • Calcium Signaling

Background:

  • Heterogeneous spatiotemporal patterns of cytosolic Ca2+ are observed in beating cardiac cells and linked to contraction.
  • Spatial heterogeneity of intracellular Ca2+ in non-beating cardiomyocytes is known, but its functional role in resting cells is unclear.

Purpose of the Study:

  • To investigate the functional implications of spatial heterogeneity of intracellular Ca2+ distribution in resting cardiomyocytes.
  • To determine if adenosine's protective effects are uniform across different intracellular Ca2+ domains.

Main Methods:

  • Utilized epifluorescent digital imaging to visualize distinct cytosolic Ca2+ domains in single, non-beating, fluo-3-loaded cardiomyocytes.
  • Applied extracellular K+ (16 mM) to induce Ca2+ loading and observed the effects of adenosine (1 mM) on this response.

Main Results:

  • Distinct domains of lower (0.17 microM) and higher (0.37 microM) basal cytosolic Ca2+ concentrations were identified.
  • Extracellular K+ uniformly increased cytosolic Ca2+ across all domains.
  • Adenosine selectively inhibited K+-induced Ca2+ loading in lower basal Ca2+ domains, but not in higher basal Ca2+ domains.

Conclusions:

  • The response to adenosine's protective action is heterogeneous within a single resting cardiomyocyte.
  • Basal Ca2+ concentration within a cytosolic domain dictates adenosine's domain-specific cytoprotective effect.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...